Physician profile
James W Holmes
NPI 1245274414
$2,223.07
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $325 · 2021: $628 · 2022: $495 · 2023: $300 · 2024: $15.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $466.68 | 2019-2023 | Xifaxan |
| Amgen INC. | $402.23 | 2019-2023 | Prolia, Evenity |
| Vanda Pharmaceuticals INC. | $278.49 | 2019-2023 | Hetlioz |
| Avanir Pharmaceuticals, INC. | $130.54 | 2021-2022 | |
| Novo Nordisk INC | $121.06 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $112.55 | 2023 | Fasenra |
| Biohaven Pharmaceutical Holding Company LTD. | $85.27 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $83.29 | 2021 | |
| Sunovion Pharmaceuticals INC. | $75.41 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.36 | 2019-2022 | |
| Genentech USA, INC. | $49.32 | 2019-2021 | |
| Abbvie INC. | $46.65 | 2021 | |
| Pfizer INC. | $44.26 | 2019-2020 | |
| Mylan Specialty L.P. | $39.41 | 2023 | Yupelri |
| Kowa Pharmaceuticals America, INC. | $37.27 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $36.16 | 2019-2022 | |
| Dexcom, INC. | $32.38 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.90 | 2020-2021 | |
| Exeltis, USA INC. | $21.20 | 2021 | |
| Scynexis, INC. | $14.99 | 2022 | |
| Shire North American Group INC | $13.75 | 2019 | |
| Lilly USA, LLC | $13.74 | 2022 | |
| Scilex Pharmaceuticals INC. | $13.73 | 2019 | |
| Adlon Therapeutics L.P. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.